Serotype

A serotype or serovar is a distinct variation within a species of bacteria or virus or among immune cells of different individuals. These microorganisms, viruses, or cells are classified together based on their shared reactivity between their surface antigens and a particular antiserum, allowing the classification of organisms to a level below the species. A group of serovars with common antigens is called a serogroup or sometimes serocomplex.^{[clarification needed]}

Serotyping often plays an essential role in determining species and subspecies. The Salmonella genus of bacteria, for example, has been determined to have over 2600 serotypes. Vibrio cholerae, the species of bacteria that causes cholera, has over 200 serotypes, based on cell antigens. Only two of them have been observed to produce the potent enterotoxin that results in cholera: O1 and O139.^{[citation needed]}

Serotypes were discovered in hemolytic streptococci by the American microbiologist Rebecca Lancefield in 1933.

Serotyping is the process of determining the serotype of an organism, using prepared antisera that bind to a set of known antigens. Some antisera detect multiple known antigens and are known as polyvalent or broad; others are monovalent. For example, what was once described as HLA-A9 is now subdivided into two more specific serotypes ("split antigens"), HLA-A23 and HLA-A24. As a result, A9 is now known as a "broad" serotype. For organisms with many possible serotypes, first obtaining a polyvalent match can reduce the number of tests required.

The binding between a surface antigen and the antiserum can be experimentally observed in many forms. A number of bacteria species, including Streptococcus pneumoniae, display the Quellung reaction visible under a microscope. Others such as Shigella (and E. coli) and Salmonella are traditionally detected using a slide agglutination test. HLA types are originally determined with the complement fixation test. Newer procedures include the latex fixation test and various other immunoassays.

"Molecular serotyping" refers to methods that replace the antibody-based test with a test based on the nucleic acid sequence – therefore actually a kind of genotyping. By analyzing which surface antigen-defining allele(s) are present, these methods can produce faster results. However, their results may not always agree with traditional serotyping, as they can fail to account for factors that affect the expression of antigen-determining genes.

The immune system is capable of discerning a cell as being 'self' or 'non-self' according to that cell's serotype. In humans, that serotype is largely determined by human leukocyte antigen (HLA), the human version of the major histocompatibility complex. Cells determined to be non-self are usually recognized by the immune system as foreign, causing an immune response, such as hemagglutination. Serotypes differ widely between individuals; therefore, if cells from one human (or animal) are introduced into another random human, those cells are often determined to be non-self because they do not match the self-serotype. For this reason, transplants between genetically non-identical humans often induce a problematic immune response in the recipient, leading to transplant rejection. In some situations, this effect can be reduced by serotyping both recipient and potential donors to determine the closest HLA match.

Most bacteria produce antigenic substances on the outer surface that can be distinguished by serotyping.